GMAB Latest Headlines

Genmab A/S (0MGB) Receives a Buy from Barclays

at www.tipranks.com (Tue, 20-Oct 2:55 AM)

Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), Genmab (GMAB) and Neogen (NEOG)

at www.tipranks.com (Mon, 19-Oct 12:00 PM)

Genmab Maintained at Buy as DARZALEX Strength and Oncology Pipeline Support Unchanged $50 Price Target

at www.tipranks.com (Mon, 19-Oct 6:35 AM)

Genmab discloses Darwin Global stake at 5.11% of voting rights

Market Chameleon (Mon, 5-Oct 11:04 AM)

Genmab Highlights Rina-S Responses in Platinum-Resistant Ovarian Cancer, with 51% of Responders Still in Response at One Year

Market Chameleon (Mon, 5-Oct 7:08 AM)